Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market Forecasts to 2017 Now Available at ReportsandReports

DALLAS, November 1, 2010 - ReportsandReports announces it will carry Peripheral Arterial Disease
(PAD) - Pipeline Assessment and Market Forecasts to 2017 Research Report in
its store.

Browse the complete Report on:
www.reportsnreports.com/Reports/37204-peripheral-arterial-disease-pad-
pipeline-assessment-and-marke.html

Browse All Manufacturing & Construction Reports:
www.reportsnreports.com/market-research/pharmaceuticals/

Browse All GlobalData Research Reports at
www.reportsnreports.com/publishers/globaldata/

GlobalData, the industry analysis specialist, has released its new
report, "Peripheral Arterial Disease (PAD) - Pipeline Assessment and Market
Forecasts to 2017". The report is an essential source of information and
analysis on the global PAD market. The report identifies the key trends
shaping and driving the global PAD market. The report also provides insights
on the prevalent competitive landscape and the emerging players expected to
significantly alter the market positioning of the current market leaders.
Most importantly, the report provides valuable insights on the pipeline
products within the global PAD sector. This report is built using data and
information sourced from proprietary databases, primary and secondary
research and in-house analysis by GlobalData's team of industry experts.

The global PAD therapeutics market accounted for approximately $606m in
2009. In 2001, the market was valued at $405m and it grew at an approximate
CAGR of 5.2% between 2001 and 2009. The global PAD therapeutics market is
expected to reach $1 billion by 2017 growing at a CAGR of 6.5% between 2009
and 2017. The primary factor contributing to the increase in growth over the
forecast period is the increase in disease incidence and the launch of new
first-in-class drugs. Presently the therapeutic regimen for PAD consists of
antiplatelet agents such as clopidogrel (Plavix) and ticlopidine (Ticlid).
Blood thinners such as pentoxifyline (Trental) and Cilostazol (Pletal) are
also prescribed. Like most cardiovascular complications, aspirin is used as a
complementary drug in combination with the above mentioned drugs.

Scope

The report provides information on the key drivers and challenges of the
PAD market. Its scope includes: - Annualized global PAD market revenues data
from 2001 to 2009, forecast for eight years to 2017. - Pipeline analysis data
providing a split across the different phases, mechanisms of action being
developed and emerging trends. Pipeline candidates fall under major
therapeutic classes such as of gene therapy, stem cell therapy, platelet
aggregation inhibitor, Hydroxymethylglutaryl-CoA reductase inhibitor,
monoclonal antibody, micro RNA, protein kinase modulator, Y2 agonist, and
PPAR (Peroxisome Proliferator Activated Receptor) agonist. - Analysis of the
current and future competition in the global PAD market. Key market players
covered are Sanofi Aventis, Indigo pharmaceuticals, BioMarin Pharmaceutical,
and AnGes MG Inc. - Insightful review of the key industry drivers, restraints
and challenges. Each trend is independently researched to provide a
qualitative analysis of its implications. - Key topics covered include
strategic competitor assessment, market characterization, unmet needs and the
implications for the PAD therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow
you to: - Develop and design your in-licensing and out-licensing strategies
through a review of pipeline products and technologies and by identifying the
companies with the most robust pipeline. - Develop business strategies by
understanding the trends shaping and driving the global PAD market. - Drive
revenues by understanding the key trends, innovative products and
technologies, market segments and companies likely to impact the global PAD
market in future. - Formulate effective sales and marketing strategies by
understanding the competitive landscape and by analyzing the performance of
various competitors. - Identify emerging players with potentially strong
product portfolios and create effective counter-strategies to gain a
competitive advantage. - Organize your sales and marketing efforts by
identifying the market categories and segments that present maximum
opportunities for consolidations, investments and strategic partnerships.
- What's the next big thing in the global PAD market landscape? - Identify,
understand and capitalize.

Browse All Specific Markets: www.reportsnreports.com/tagIndex.aspx

Browse All Latest Reports:
www.reportsnreports.com/LatestReport.aspx

Related Reports

Peripheral Arterial Disease (PAD) - Drug Pipeline Analysis and Market
Forecasts to 2016 (
www.reportsnreports.com/reports/16053-peripheral-arterial-disease-pad-
drug-pipeline-analysis-and-ma.html)

Peripheral Arterial Disease Therapy Area Pipeline Report (
www.reportsnreports.com/reports/32464-peripheral-arterial-disease-ther
apy-area-pipeline-report.html)

Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017
(www.reportsnreports.com/reports/36584-influenza-vaccines-pipeline-ass
essment-and-market-forecasts-to-.html)

Head and Neck Cancer - Pipeline Assessment and Market Forecast to 2017
(www.reportsnreports.com/reports/36585-head-and-neck-cancer-pipeline-a
ssessment-and-market-forecast-to.html)

Rheumatoid Arthritis - Pipeline Assessment and Market Forecasts to 2017
(www.reportsnreports.com/reports/37160-rheumatoid-arthritis-pipeline-a
ssessment-and-market-forecasts-t.html)

Systemic Lupus Erythematosus - Pipeline Assessment and Market Forecasts
to 2017 (
www.reportsnreports.com/reports/37161-systemic-lupus-erythematosus-pip
eline-assessment-and-market-for.html)

Anemia - Pipeline Assessment and Market Forecasts to 2017 (
www.reportsnreports.com/reports/37162-anemia-pipeline-assessment-and-m
arket-forecasts-to-2017.html)

Growth Hormone Deficiency (GHD) - Pipeline Assessment and Market
Forecasts to 2017 (
www.reportsnreports.com/reports/37205-growth-hormone-deficiency-ghd-pi
peline-assessment-and-market-.html)

Type 1 Diabetes - Drug Pipeline Assessment and Market Forecasts to 2017
(www.reportsnreports.com/reports/25702-type-1-diabetes-drug-pipeline-a
ssessment-and-market-forecasts-t.html)

Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market
Forecasts to 2017 (
www.reportsnreports.com/reports/27388-hormone-replacement-therapy-in-m
enopause-pipeline-assessment-an.html)

(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser's URL address field. Remove the
space if one exists.)

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth
market research studies of over 5000 micro markets, and 25 industry specific
websites. Our client list boasts almost all well-known publishers of such
reports across the globe. We as a third-party reseller of market research
reports employ a number of marketing tools, such as press releases,
email-marketing and effective search-engine optimization techniques to drive
revenues for our clients. We also provide 24/7 online and offline support
service to our customers.

    Contact:

    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004

    www.reportsnreports.com/

Contact: Ms. Sunita, 7557 Rambler road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004.